The Brain H3-Receptor as a Novel Therapeutic Target for Vigilance and Sleep–wake Disorders

Biochemical Pharmacology - Netherlands
doi 10.1016/j.bcp.2007.01.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Irisin: As a Therapeutic Target for Metabolic Disorders

Journal of Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2018English

Enhanced Histaminergic Neurotransmission and Sleep-Wake Alterations, a Study in Histamine H3-Receptor Knock-Out Mice

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2013English

GPR35 as a Novel Therapeutic Target

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2011English

The Potential of Oxytocin as a Therapeutic Target for Psychiatric Disorders

Expert Opinion on Therapeutic Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2016English

Prostanoid Receptor EP2 as a Therapeutic Target

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2013English

GABAergic Signaling as Therapeutic Target for Autism Spectrum Disorders

Frontiers in Pediatrics
Child HealthPediatricsPerinatology
2014English

The Discovery of LML134, a Histamine H3 Receptor Inverse Agonist for the Clinical Treatment of Excessive Sleep Disorders

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2019English

Αvβ1 Integrin as a Novel Therapeutic Target for Tissue Fibrosis

Annals of Translational Medicine
Medicine
2016English

Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis

Frontiers in Pharmacology
Pharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy